Ildong Pharmaceutical Co., Ltd.

KSE 249420.KS

Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: -46.55%

Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) is -46.55% for the year ending December 31, 2023, a 37.38% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was -74.34%, a -12.58% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was -66.03%, a -1,191.04% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was -5.11%, a 3.79% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was -5.32%, a -215.68% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
Loading...
SV Wall Street
KSE: 249420.KS

Ildong Pharmaceutical Co., Ltd.

CEO Yun Paul Woongsup
IPO Date Aug. 31, 2016
Location South Korea
Headquarters 2, Baumoe-ro 27-gil
Employees 1,020
Sector Consumers Staples
Industries
Description

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Similar companies

185750.KS

Chong Kun Dang Pharmaceutical Corp.

USD 56.39

-4.53%

000100.KS

Yuhan Corporation

USD 83.97

-5.00%

128940.KS

Hanmi Pharm. Co., Ltd.

USD 159.35

-4.24%

003850.KS

Boryung Corporation

USD 6.82

-1.91%

069620.KS

Daewoong pharmaceutical Co.,Ltd

USD 89.76

-4.42%

StockViz Staff

February 4, 2025

Any question? Send us an email